Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 28, 2026 Filed Sep 30, 2026 06:22 UTC |
Alila Hector WDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001493152-26-045006 · ownership.xml · derivative · entry 1 Alila Hector W · CIK 0001312210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 50,000 shares Expires 2031-09-28 F1 · date: On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan. F2 · derivative.exercise_date: The options vested immediately on September 28, 2026. F3 · balance_after: Includes the options previously issued to the Reporting Person. Read SEC document |
| September 28, 2026 Filed Sep 30, 2026 06:18 UTC |
Melton ChristopherDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001493152-26-045002 · ownership.xml · derivative · entry 1 Melton Christopher · CIK 0001533552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 50,000 shares Expires 2031-09-28 F1 · date: On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan. F2 · derivative.exercise_date: The options vested immediately on September 28, 2026. F3 · balance_after: Includes the options previously issued to the Reporting Person. Read SEC document |
| September 28, 2026 Filed Sep 30, 2026 06:11 UTC |
Meadows BrianChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001493152-26-044990 · ownership.xml · derivative · entry 1 Meadows Brian · CIK 0002055703 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-09-28 F1 · date: On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan. F2 · derivative.exercise_date: The options vested immediately on September 28, 2026. Read SEC document |
| September 28, 2026 Filed Sep 30, 2026 06:14 UTC |
Galeta Christopher MatthewDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001493152-26-044996 · ownership.xml · derivative · entry 1 Galeta Christopher Matthew · CIK 0002089464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 25,000 shares Expires 2031-09-28 F1 · date: On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan. F2 · derivative.exercise_date: The options vested immediately on September 28, 2026. F3 · balance_after: Includes the options previously issued to the Reporting Person. Read SEC document |
| July 23, 2026 Filed Jul 28, 2026 20:15 UTC |
John BrianDirector · Interim CFO
|
OtherCommon Stock | 150,000 | $1.00 | $150,000.00 |
DisclosureSEC source: 0001493152-26-035004 · ownership.xml · nonDerivative · entry 1 John Brian · CIK 0001534699 · Director · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 F1 · shares: Represents redemption of 150,000 shares of common stock of the Issuer at approximately $1.00 per share pursuant to that certain Share Redemption Agreement dated July, 10, 2026, by and between the Issuer and BK Investments LLC, an entity owned by the Reporting Person, the Issuer's Chairman and Interim Chief Financial Officer. Read SEC document |
| March 27, 2026 Filed Mar 27, 2026 22:56 UTC |
WILSON GLYNNDirector · Chief Executive Officer
|
Disposition to issuerCommon Stock | 1,500,000 | $0.50 | $750,000.00 |
DisclosureSEC source: 0001493152-26-013341 · ownership.xml · nonDerivative · entry 1 WILSON GLYNN · CIK 0001405625 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 672,592 F1 · kind: Represents redemption of 1,500,000 shares of common stock of the Issuer at approximately $0.50 per share pursuant to that certain Share Redemption Agreement signed by the Reporting Person and the Issuer on March 19, 2026. F2 · balance_after: The number of shares of common stock beneficially owned following the reported transaction includes Dr. Wilson's ownership of (i) 126,720 restricted stock units of common stock of the Issuer of which zero have vested, (ii) 45,872 restricted stock units of common stock of the Issuer of which zero have vested, and (iii) 500,000 shares of common stock. Read SEC document |
| March 27, 2026 Filed Mar 27, 2026 22:56 UTC |
John BrianDirector
|
Disposition to issuerCommon Stock | 1,250,000 | $1.00 | $1,250,000.00 |
DisclosureSEC source: 0001493152-26-013340 · ownership.xml · nonDerivative · entry 1 John Brian · CIK 0001534699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 F1 · kind: Represents redemption of 1,250,000 shares of common stock of the Issuer at approximately $1.00 per share pursuant to that certain Share Redemption Agreement signed by the Reporting Person and the Issuer on March 19, 2026. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 20:49 UTC |
Moore Tyler ThomasChief Financial Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-027836 · ownership.xml · nonDerivative · entry 2 Moore Tyler Thomas · CIK 0002087198 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 F2 · shares: On December 11, 2025, on recommendation of the Compensation Committee of the Board of the Issuer, the Board approved the issuance of 30,000 restricted stock units of common stock of the Issuer, under its equity incentive plan. The RSU shares will fully vest on December 11, 2026. The vesting of shares is subject to Mr. Moore's continued service with the Company. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 20:49 UTC |
Moore Tyler ThomasChief Financial Officer
|
GrantCommon Stock | 270,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-027836 · ownership.xml · nonDerivative · entry 1 Moore Tyler Thomas · CIK 0002087198 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,000 F1 · shares: On December 11, 2025, on recommendation of the Compensation Committee of the Board of Directors ("Board") of the Issuer, the Board approved the issuance of 270,000 restricted stock units of common stock of the Issuer, under its equity incentive plan. The RSU shares will fully vest on June 11, 2026. The vesting of shares is subject to Mr. Moore's continued services with the Company. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 20:55 UTC |
Galeta Christopher MatthewDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001493152-25-027840 · ownership.xml · derivative · entry 1 Galeta Christopher Matthew · CIK 0002089464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-12-11 F1 · date: On December 11, 2025, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan. F2 · derivative.exercise_date: The options vested immediately on December 11, 2025. Read SEC document |
| December 11, 2025 Filed Dec 16, 2025 02:37 UTC |
John BrianDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001493152-25-027850 · ownership.xml · derivative · entry 1 John Brian · CIK 0001534699 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-12-11 F1 · date: On December 11, 2025, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved the grant of 100,000 options, under the Company's equity incentive plan. F2 · derivative.exercise_date: The options shall fully vest on June 11, 2026. Vesting of options is subject to the Reporting Person's continued services with the Issuer. F3 · balance_after: Does not include the 2,000,000 shares of common Stock of the Issuer owned by the Reporting Person. Read SEC document |
| December 11, 2025 Filed Dec 16, 2025 01:51 UTC |
WILSON GLYNNDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 45,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-027838 · ownership.xml · nonDerivative · entry 2 WILSON GLYNN · CIK 0001405625 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,172,592 F2 · shares: On December 11, 2025, on recommendation of the Compensation Committee of the Board of the Issuer, the Board approved the issuance of 45,872 restricted stock units of common stock of the Issuer, under its equity incentive plan. The RSU shares will fully vest on December 11, 2026. The vesting of shares is subject to Dr. Wilson's continued service with the Company. F3 · balance_after: The number of shares of common stock beneficially owned following the reported transactions includes Dr. Wilson's ownership of 2,000,000 shares of common stock. Read SEC document |
| December 11, 2025 Filed Dec 16, 2025 01:51 UTC |
WILSON GLYNNDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 126,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-027838 · ownership.xml · nonDerivative · entry 1 WILSON GLYNN · CIK 0001405625 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,126,720 F1 · shares: On December 11, 2025, on recommendation of the Compensation Committee of the Board of Directors ("Board") of the Issuer, the Board approved the issuance of 126,720 restricted stock units of common stock of the Issuer, under its equity incentive plan. The RSU shares will fully vest on June 11, 2026. The vesting of shares is subject to Dr. Wilson's continued services with the Company. F3 · balance_after: The number of shares of common stock beneficially owned following the reported transactions includes Dr. Wilson's ownership of 2,000,000 shares of common stock. Read SEC document |
| December 11, 2025 Filed Dec 16, 2025 01:57 UTC |
Melton ChristopherDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001493152-25-027842 · ownership.xml · derivative · entry 1 Melton Christopher · CIK 0001533552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-12-11 F1 · date: On December 11, 2025, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan. F2 · derivative.exercise_date: The options vested immediately on December 11, 2025. Read SEC document |
| December 11, 2025 Filed Dec 16, 2025 13:33 UTC |
Alila Hector WDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001493152-25-027895 · ownership.xml · derivative · entry 1 Alila Hector W · CIK 0001312210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-12-11 F1 · date: On December 11, 2025, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan. F2 · derivative.exercise_date: The options vested immediately on December 11, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.